Ethionamide

This classification denotes an antitubercular agent with the molecular formula C8H10N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OAY8ORS3CQ, chemically known as cyclohexanol, 1-ethynyl-, carbamate but generally known as ethionamide, which bears US NIH Compound Identifier 3284. European Medicines Agency schedules Ethionamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07278MIG. The term ETHIONAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules ethionamide in its Anatomical Therapeutic Chemical (ATC) Classification. ETHIONAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ethionamide under HS 29333999 and SITC 51574. As of Q4 2014, ETHIONAMIDE remains the US FDA Preferred Term for this commodity. Ethionamide bears US NLM identifiers UMLS ID C0733402 and NCI Concept Code C47522. SMILES: O(C1(CCCCC1)C#C)C(=O)N.